our mission

To develop and commercialize self-administered parenteral medicines that optimize clinical benefits with enhanced cost effective health outcomes

news / press releases

  • 26 January 2016

    Antares Pharma Announces CEO Transition
  • 7 January 2016

    Antares Pharma to Present at the 34th Annual J.P. Morgan Healthcare Conference
  • 14 December 2015

    Antares Pharma Announces the FDA Approval of Sumatriptan Injection USP
  • 2 December 2015

    Antares Pharma to Present at the 26th Annual Oppenheimer Healthcare Conference
  • 20 November 2015

    Antares Pharma Announces PosterPoster Presentation at the Sexual medicine Society Scientific Annual Meeting
  • 20 November 2015

    Antares Pharma Announces Poster Presentation at the Sexual Medicine Society Scientific Annual Meeting

latest products & technology

 

Otrexup (methotrexate) injection for subcutaneous use only.

Learn More >>